AstraZeneca Covid vaccine sales jump to $894 mln, updates forecasts

Vials labelled "Astra Zeneca COVID-19 Coronavirus Vaccine" and a syringe are seen in front of a displayed AstraZeneca logo, in this illustration photo taken March 14, 2021. REUTERS/Dado Ruvic/Illustration/File Photo/File Photo
AstraZeneca's Covid-19 vaccine sales more than tripled to $894 million in the second quarter from the previous three months but shaved off 1 US cent from earnings, and the drugmaker updated its 2021 forecasts on Thursday to include sales from its Alexion unit.